TI
OCUL icon

Trexquant Investment’s Ocular Therapeutix OCUL Stock Holding History

Trexquant Investment’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Buy
+418,781
New +$3.8M 0.02% 844
2026
Q1 		– Sell
-592,877
Closed -$7.2M – 1969
2025
Q4 		$7.2M Buy
592,877
+405,095
+216% +$4.92M 0.06% 425
2025
Q3 		$2.2M Buy
+187,782
New +$2.25M 0.02% 877
2022
Q2 		– Sell
-71,224
Closed -$353K – 1756
2022
Q1 		$353K Buy
+71,224
New +$395K 0.02% 924
2021
Q4 		– Sell
-36,840
Closed -$368K – 1534
2021
Q3 		$368K Buy
36,840
+20,554
+126% +$231K 0.03% 658
2021
Q2 		$231K Sell
16,286
-14,977
-48% -$228K 0.02% 839
2021
Q1 		$513K Buy
+31,263
New +$602K 0.05% 498
2020
Q4 		– Sell
-32,791
Closed -$250K – 1362
2020
Q3 		$250K Buy
32,791
+20,539
+168% +$170K 0.02% 1002
2020
Q2 		$102K Buy
+12,252
New +$81.2K 0.01% 1114
2018
Q4 		– Sell
-20,190
Closed -$139K – 1233
2018
Q3 		$139K Buy
+20,190
New +$127K 0.01% 875
2017
Q1 		– Sell
-21,663
Closed -$181K – 1247
2016
Q4 		$181K Buy
+21,663
New +$168K 0.03% 850
2016
Q1 		– Sell
-13,731
Closed -$129K – 1097
2015
Q4 		$129K Buy
13,731
+2,959
+27% +$31.9K 0.01% 963
2015
Q3 		$151K Sell
10,772
-4,928
-31% -$99K 0.01% 988
2015
Q2 		$329K Buy
15,700
+6,352
+68% +$157K 0.04% 782
2015
Q1 		$392K Buy
+9,348
New +$307K 0.04% 777

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's OCUL Position: Q2 2026 in Review

Trexquant Investment opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 418,781 shares worth $4.11M. The stake represents 0.02% of the portfolio and ranks #844 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in OCUL as recently as Q4 2025.

Trexquant Investment first reported a position in OCUL in Q1 2015 and has held it in 15 quarters since. The position peaked at $7.2M in Q4 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Trexquant Investment held 418,781 shares of Ocular Therapeutix worth $4.11M as of Q2 2026.
  • Ocular Therapeutix was a new Trexquant Investment position in Q2 2026.
  • Ocular Therapeutix made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #844 holding.
  • Trexquant Investment first reported a position in Ocular Therapeutix in Q1 2015 and has held it in 15 quarters since.
  • Trexquant Investment's Ocular Therapeutix position peaked at $7.2M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.